Scantox offers the Big Blue® Transgenic Rodent Somatic and Germ Cell Gene Mutation Assay to support mutagenicity assessment in compliance with OECD 488 guideline.
Service information
Big Blue® studies play a key role in assessing in vivo mutagenicity risk for materials where pre-existing data indicates a potential genotoxicity risk to human health and the environment. Following continued growth in the assay and a large laboratory footprint expansion, Scantox now offers the assay in both rat and mice in a wide array of tissue types.
We presented the establishment of Big Blue® laboratory proficiency at SOT 2023. To view our poster, click here.
The addition of the Big Blue® Transgenic Rodent Somatic and Germ Cell Gene Mutation Assay has strengthened the Scantox portfolio of OECD guideline genetic toxicology testing services. This, alongside continued investment and growth in capacity within our existing service offerings, has enhanced Scantox credentials as the leading specialist genetic toxicology contract research organisation. We now have the capability to support clients from their very first genetic toxicology screens right through to helping manage complex mutagenicity risk assessments.
If you would like more details on how Scantox can support your project through the conduct of OECD 488: Big Blue® Transgenic Rodent Somatic and Germ Cell Gene Mutation Assay, please contact us.